Approved for 1 INDICATIONS AND USAGE COBENFY is indicated for the treatment of schizophrenia in adults. COBENFY is a combination of xanomeline, a muscarinic agonist, and trospium chloride, a muscarinic antagonist, indicated for the treatment of schizophrenia in adults. ( 1 ). 12.1 Mechanism of Action The mechanism of action of xanomeline in the treatment of schizophrenia is unclear; however, its…
Loading full data from Know Your Drugs Institute…